Dendrimer and cancer: a patent review (2006 – present)

Author： Cai Xiaopan   Hu Jingjing   Xiao Jianru   Cheng Yiyun  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.4, 2013-04, pp. : 515-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quinoxaline derivatives: a patent review (2006 – present)

By González Mercedes   Cerecetto Hugo  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1289-1302

Informa Healthcare

Access to resources Recommend Favorite

Artemisinin derivatives: a patent review (2006 – present)

By Njuguna Nicholas M   Ongarora Dennis S B   Chibale Kelly  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1179-1203

Informa Healthcare

Access to resources Recommend Favorite

Imidazoline derivatives: a patent review (2006 – present)

By Guan Xianghong   Hu Yongzhou  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1353-1365

Informa Healthcare

Access to resources Recommend Favorite

Phenylpiperazine derivatives: a patent review (2006 – present)

By Maia Rodolfo do Couto   Tesch Roberta   Fraga Carlos Alberto Manssour  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1169-1178

Informa Healthcare

Access to resources Recommend Favorite

Plasminogen activator inhibitor-1 inhibitors: a patent review (2006 - present)

By Fortenberry Yolanda M  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 801-815

Informa Healthcare

Access to resources Recommend Favorite